ArticleScientific reports2016

Pre-Clinical Study of a Novel Recombinant Botulinum Neurotoxin Derivative Engineered for Improved Safety.

Edwin Vazquez-Cintron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.